Research Papers
Latest
Cizzle Bio Research Papers
Delve into our research to gain insights into the advancements and scientific endeavors driving our mission to improve early cancer detection and patient outcomes.
The Evidence Supporting CIZ1B: Peer-Reviewed Research on the Lung Cancer Biomarker Blood Test
A provider-focused overview of the 2026 peer-reviewed JALM study evaluating the same scalable ELISA-based CIZ1B assay now commercially available, including 94% sensitivity and 97% negative predictive value in the early-stage cohort.
A provider-focused overview of the 2026 peer-reviewed JALM study evaluating the same scalable ELISA-based CIZ1B assay now commercially available, including 94% sensitivity and 97% negative predictive value in the early-stage cohort.